Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying antirheumatic drugs
Objective To provide the initial installment of a living guideline that will provide up-to-date
guidance on the pharmacological management of patients with rheumatoid arthritis (RA) in …
guidance on the pharmacological management of patients with rheumatoid arthritis (RA) in …
Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of …
MS van der Leeuw, MA Messelink, J Tekstra… - Arthritis research & …, 2022 - Springer
Background Biological disease-modifying antirheumatic drugs (bDMARDs) are effective in
the treatment of rheumatoid arthritis. However, as bDMARDs may also lead to adverse …
the treatment of rheumatoid arthritis. However, as bDMARDs may also lead to adverse …
Tapering of etanercept is feasible in patients with rheumatoid arthritis in sustained remission: a pragmatic randomized controlled trial
D Bertrand, V Stouten, D De Cock… - Scandinavian Journal …, 2022 - Taylor & Francis
Objective In patients with rheumatoid arthritis (RA) in sustained remission, tapering of
biological disease-modifying anti-rheumatic drugs can be considered. Tapering has already …
biological disease-modifying anti-rheumatic drugs can be considered. Tapering has already …
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors
L Terslev, M Ostergaard, S Georgiadis, CH Brahe… - RMD open, 2022 - rmdopen.bmj.com
Objective To identify predictors of flare in a 2-year follow-up study of patients with
rheumatoid arthritis (RA) in sustained clinical remission tapering towards withdrawal of …
rheumatoid arthritis (RA) in sustained clinical remission tapering towards withdrawal of …
[HTML][HTML] Cost-effectiveness analysis of etanercept 25 mg maintenance therapy after treatment with etanercept 50 mg for moderate rheumatoid arthritis in the …
T Hirose, I Kawaguchi, T Murata, T Atsumi - Value in Health Regional Issues, 2022 - Elsevier
Abstract Objectives To use Markov modeling to estimate the cost-effectiveness of treatment
with etanercept 25 mg once weekly plus methotrexate (MTX) in Japanese patients with …
with etanercept 25 mg once weekly plus methotrexate (MTX) in Japanese patients with …
One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry
The aim of the study was to estimate the annual direct costs of biological therapies in
rheumatoid arthritis (RA), and to establish possible factors associated with those costs. The …
rheumatoid arthritis (RA), and to establish possible factors associated with those costs. The …
Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial
MA Messelink, MS van der Leeuw, AA den Broeder… - Trials, 2022 - Springer
Background Biological disease-modifying anti-rheumatic drugs (bDMARDs) are effective in
the treatment of rheumatoid arthritis (RA) but are expensive and increase the risk of …
the treatment of rheumatoid arthritis (RA) but are expensive and increase the risk of …
Dose Reduction of Biological Therapies in Patients with Inflammatory Arthritis: Maintaining Stable Disease Activity on Reduced Dose
L Uhrenholt - 2022 - vbn.aau.dk
This PhD thesis provides an extended summary of research carried out between 2018 and
2022 in collaboration between the Department of Rheumatology at Aalborg University …
2022 in collaboration between the Department of Rheumatology at Aalborg University …
Cost-effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment with Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE …
廣瀬智弘， ヒロセトモヒロ - 2021 - jair.repo.nii.ac.jp
ABSTRACT Objectives: To use Markov modeling to estimate the cost-effectiveness of
treatment with etanercept 25 mg once weekly plus methotrexate (MTX) in Japanese patients …
treatment with etanercept 25 mg once weekly plus methotrexate (MTX) in Japanese patients …
[引用][C] * these authors contributed equally
MA Messelink, MS van der Leeuw, J Tekstra, O Medina… - Clinical Decision Support for …, 2022